Literature DB >> 7582298

Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis.

H Nakamura1, S Fujishima, Y Waki, T Urano, K Sayama, F Sakamaki, T Terashima, K Soejima, S Tasaka, A Ishizaka.   

Abstract

We evaluated the contribution of interleukin-8 (IL-8) to the pathogenesis of idiopathic pulmonary fibrosis (IPF) by studying bronchoalveolar lavage fluid (BALF) in eight patients with IPF in the chronically progressive phase, five patients with IPF in the subacutely progressive phase, eight patients with sarcoidosis (SAR), and eight control (CTL) subjects. IL-8 levels were not increased in the BALF of the patients with IPF in the chronic phase (11.3 +/- 8.8 pg/ml), nor in that of the SAR patients (13.8 +/- 7.8 pg/ml), whereas they were increased in the BALF of patients with IPF in the subacutely progressive phase (1.93 +/- 1.10 ng/ml). We then investigated extracellular and cell-associated IL-8 in lipopolysaccharide (LPS)-stimulated BALF cells to determine the IL-8-producing potential of alveolar macrophages (AM). Following LPS stimulation of BALF cells from patients with IPF in the chronic phase, both the extracellular IL-8 in culture fluid and the cell-associated IL-8 in AM were increased as compared with those for the CTL subjects (p < 0.05 and p < 0.05, respectively). These results suggest that AM of patients with IPF are primed for IL-8 production. We conclude that IL-8 may play a role in neutrophilic alveolitis, especially during the subacute phase of IPF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582298     DOI: 10.1164/ajrccm.152.5.7582298

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Biosimulation of inflammation and healing in surgically injured vocal folds.

Authors:  Nicole Y K Li; Yoram Vodovotz; Patricia A Hebda; Katherine Verdolini Abbott
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-06       Impact factor: 1.547

2.  Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome.

Authors:  C Marie; C Fitting; C Cheval; M R Losser; J Carlet; D Payen; K Foster; J M Cavaillon
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Thrombospondin-1-deficient mice are not protected from bleomycin-induced pulmonary fibrosis.

Authors:  Michael E Ezzie; Melissa G Piper; Christine Montague; Christie A Newland; Judy M Opalek; Chris Baran; Naeem Ali; David Brigstock; Jack Lawler; Clay B Marsh
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-25       Impact factor: 6.914

4.  Serum MIP-1 alpha and IL-8 in septic patients.

Authors:  S Fujishima; J Sasaki; Y Shinozawa; K Takuma; H Kimura; M Suzuki; M Kanazawa; S Hori; N Aikawa
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

5.  Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema.

Authors:  M Tanino; T Betsuyaku; K Takeyabu; Y Tanino; E Yamaguchi; K Miyamoto; M Nishimura
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 6.  Mitochondrial Dysfunction in Pulmonary Fibrosis.

Authors:  Sunad Rangarajan; Karen Bernard; Victor J Thannickal
Journal:  Ann Am Thorac Soc       Date:  2017-11

7.  Evaluation of inflammatory cytokine secretion by human alveolar macrophages.

Authors:  J E Losa García; F M Rodríguez; M R Martín de Cabo; M J García Salgado; J P Losada; L G Villarón; A J López; J L Arellano
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

8.  Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis.

Authors:  Yurika Yogo; Seitaro Fujishima; Takashi Inoue; Fumitake Saito; Takayuki Shiomi; Kazuhiro Yamaguchi; Akitoshi Ishizaka
Journal:  Respir Res       Date:  2009-08-29

9.  The interaction of asbestos and iron in lung tissue revealed by synchrotron-based scanning X-ray microscopy.

Authors:  Lorella Pascolo; Alessandra Gianoncelli; Giulia Schneider; Murielle Salomé; Manuela Schneider; Carla Calligaro; Maya Kiskinova; Mauro Melato; Clara Rizzardi
Journal:  Sci Rep       Date:  2013-01-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.